申请人:Medinox, Inc.
公开号:EP2261200A2
公开(公告)日:2010-12-15
In accordance with the present invention, there are provided modified forms of nonsteroidal anti-inflammatory drugs (NSIADs). Modified NSIADs according to the invention provide a new class of anti-inflammatory agent which provides the therapeutic benefits of NSIADs while causing a much lower incidence of side-effects then typically observed with such agents
根据本发明,提供了改良形式的非甾体抗炎药(NSIADs)。根据本发明的改良型 NSIADs 提供了一类新的抗炎药物,它具有 NSIADs 的治疗功效,同时副作用的发生率比通常观察到的此类药物要低得多